G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 51.25 HKD -0.1%
Market Cap: 52B HKD
Have any thoughts about
Giant Biogene Holding Co Ltd?
Write Note
Giant Biogene Holding Co Ltd
/
Income Statement
/
Net Income (Common)

Giant Biogene Holding Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Giant Biogene Holding Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
G
Giant Biogene Holding Co Ltd
HKEX:2367
Net Income (Common)
¥1.5B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Net Income (Common)
¥3B
CAGR 3-Years
-11%
CAGR 5-Years
-4%
CAGR 10-Years
0%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Net Income (Common)
¥657.2m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Net Income (Common)
¥1.4B
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Net Income (Common)
¥756.8m
CAGR 3-Years
12%
CAGR 5-Years
24%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Net Income (Common)
¥1.7B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Giant Biogene Holding Co Ltd
Glance View

Market Cap
52.7B HKD
Industry
Consumer products

In the bustling entrepreneurial landscape of China's Xi'an comes a formidable player in the skincare industry—Giant Biogene Holding Co Ltd. Founded in the early 2000s, the company quickly established itself as a pioneer in the biocosmetic field, underpinned by its commitment to leveraging cutting-edge biotechnologies. Positioned at the intersection of science and beauty, Giant Biogene concentrates on the research, production, and sale of bioactive skincare ingredients and products. These formulations, rich in proteins and polypeptides, target aspiring consumers eager to invest in beauty products that promise both efficacy and luxury. The company’s emphasis on integrating advanced bioengineering techniques with traditional Chinese medicinal practices has allowed it to carve out a distinct niche in the market, often emphasizing the scientific rigor and innovative spirit behind their product lines. Giant Biogene's revenue flows primarily from its comprehensive suite of skincare products, which are distributed through a variety of channels, including e-commerce platforms and retail partnerships. The company taps into the rising demand for premium anti-aging and skin-repair products in China's robust beauty market. This inclination towards advanced skincare solutions is largely fueled by an increasingly affluent middle class that places high value on personal care and appearance. The company further augments its revenue streams by developing proprietary formulas and licensing these innovative technologies to other skincare brands, thereby capitalizing on its formidable R&D capabilities. By maintaining a symbiotic relationship between its research endeavors and market strategy, Giant Biogene continues to thrive as a vanguard of scientific beauty solutions amid evolving consumer preferences.

Intrinsic Value
53.88 HKD
Undervaluation 5%
Intrinsic Value
Price
G
What is Intrinsic Value?

See Also

What is Giant Biogene Holding Co Ltd's Net Income (Common)?
Net Income (Common)
1.5B CNY

Based on the financial report for Dec 31, 2023, Giant Biogene Holding Co Ltd's Net Income (Common) amounts to 1.5B CNY.

What is Giant Biogene Holding Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
21%

Over the last year, the Net Income (Common) growth was 45%. The average annual Net Income (Common) growth rates for Giant Biogene Holding Co Ltd have been 21% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.